Top

Reactions Weekly

Published in:

01-09-2017 | Case report

Adalimumab/ustekinumab

Non-pulmonary tuberculosis and tuberculous lymphadenitis: case report

Published in: Reactions Weekly | Issue 1/2017

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Shiratsuki R, et al. A case of tuberculosis during adalimumab administration for psoriasis after antituberculosis prophylactic administration. Nishinihon Journal of Dermatology 79: 235-240, No. 3, Jan 2017 [Japanese; summarised from a translation] - JapanCrossRef

Title: Adalimumab/ustekinumab
Non-pulmonary tuberculosis and tuberculous lymphadenitis: case report
Publication date: 01-09-2017
Publisher: Springer International Publishing
Published in: Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-017-35499-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Adalimumab/ustekinumab

Non-pulmonary tuberculosis and tuberculous lymphadenitis: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2017

Imipramine/milnacipran/paroxetine

Dexamethasone

Haloperidol

Pembrolizumab

Imipramine overdose

Oxycodone overdose